D03639 | Daclizumab (USAN/INN) |
D03058 | Basiliximab (USAN/INN); Basiliximab (genetical recombination) (JAN) <JP/US> |
D02934 | Anakinra (USAN/INN) <US> |
D06635 | Rilonacept (USAN/INN) <US> |
D09214 | Ustekinumab (USAN/INN); Ustekinumab (genetical recombination) (JAN) <JP/US> |
D02596 | Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN) <JP/US> |
D09315 | Canakinumab (USAN/INN); Canakinumab (genetical recombination) (JAN) <JP/US> |
D09588 | Briakinumab (USAN/INN) |
D09967 | Secukinumab (USAN/INN); Secukinumab (genetical recombination) (JAN) <JP/US> |
D09669 | Siltuximab (USAN/INN) <US> |
D10061 | Brodalumab (USAN); Brodalumab (genetical recombination) (JAN) <JP/US> |
D10071 | Ixekizumab (USAN); Ixekizumab (genetical recombination) (JAN) <JP/US> |
D10161 | Sarilumab (USAN); Sarilumab (genetical receombination) (JAN) <JP/US> |
D10080 | Sirukumab (USAN); Sirukumab (genetical recombination) (JAN) |
D10438 | Guselkumab (USAN); Guselkumab (genetical recombination) (JAN) <JP/US> |
D10400 | Tildrakizumab (USAN); Tildrakizumab (genetical recombination) (JAN) <JP/US> |
D11052 | Risankizumab (USAN/INN); Risankizumab (genetical recombination) (JAN) <JP/US> |
D11079 | Satralizumab (USAN/INN); Satralizumab (genetical recombination) (JAN) <JP/US> |
D11550 | Bimekizumab (USAN/INN); Bimekizumab (genetical recombination) (JAN) <JP> |
D12066 | Spesolimab (USAN/INN); Spesolimab (genetical recombination) (JAN) |
D09190 | Anti-human thymocyte immunoglobulin, rabbit (JAN) <JP/US> |
D01583 | Pirfenidone (JAN/USAN/INN) <JP/US> |
D08985 | Reslizumab (USAN) <US> |
D04923 | Mepolizumab (USAN/INN); Mepolizumab (genetical recombination) (JAN) <JP/US> |
D09874 | Benralizumab (USAN/INN); Benralizumab (genetical recombination) (JAN) <JP/US> |
D09979 | Tralokinumab (USAN/INN); Tralokinumab (genetical recombination) (JAN) <US> |
D04748 | Lisofylline (USAN/INN) |
D06556 | Apilimod mesylate (USAN) |
D08857 | Anrukinzumab (USAN) |
D09615 | Fezakinumab (USAN/INN) |
D09633 | Lebrikizumab (USAN/INN); Lebrikizumab (genetical recombination) (JAN) |
D09897 | Enokizumab (USAN/INN) |
D09911 | Gevokizumab (USAN/INN) |
D10902 | Afasevikumab (USAN/INN) |
D10912 | Brazikumab (USAN/INN) |
D11080 | Nemolizumab (INN); Nemolizumab (genetical recombination) (JAN) <JP> |
D11123 | Mirikizumab (USAN/INN); Mirikizumab (genetical recombination) (JAN) |
D11127 | Tibulizumab (USAN/INN) |
D11449 | Etokimab (USAN) |
D11759 | Isunakinra (USAN/INN) |
D11999 | Itepekimab (USAN/INN) |
D12169 | Depemokimab (USAN) |
D12278 | Izokibep (USAN/INN) |
D12306 | Ordesekimab (USAN) |
D12370 | Lutikizumab (INN) |
D12375 | Tozorakimab (USAN/INN) |